{
    "2019-08-29": [
        [
            {
                "time": "2019-08-29",
                "original_text": "Big Pharma kills signature drug at center of $5.8 billion South S.F. deal",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "signature drug",
                        "$5.8 billion",
                        "South S.F. deal"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "Health Care Sector Update for 08/29/2019: AZN, ABBV, IBIO",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "AZN",
                        "ABBV",
                        "IBIO"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "UPDATE 1-AbbVie abandons late-stage lung cancer asset Rova-T",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "abandons",
                        "late-stage",
                        "lung cancer",
                        "Rova-T"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Discontinues",
                        "Phase III",
                        "Trial",
                        "Small-Cell Lung Cancer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "AbbVie is shutting down its troubled Rova-T R&D program",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "shutting down",
                        "Rova-T",
                        "R&D program"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "AbbVie terminates late-stage lung cancer trial",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "terminates",
                        "late-stage",
                        "lung cancer",
                        "trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-29",
                "original_text": "AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Discontinues",
                        "Rovalpituzumab Tesirine",
                        "Rova-T",
                        "Research and Development Program"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}